卢旺达人类乳头瘤病毒疫苗覆盖率:按出生队列的人群水平分析
卢旺达2011年成为首个实施全国HPV疫苗接种规划的非洲国家,初始为学校年级靶向补种,后转为仅常规接种12岁女孩。该研究基于2011-2018年EPI数据按出生队列估算覆盖率,显示1,156,863名女孩接种首剂,达 eligible target 的98%,常规靶向队列覆盖率达80-90%。
要点
- 2011-2018年共1,156,863名女孩接种首剂HPV疫苗,相当于 eligible target 的98%。
- 中位接种年龄从2011-2013年的15岁(IQR 13-16)降至2015-2018年的12岁。
- 针对2001-2006出生队列(12岁常规接种)的人群覆盖率相对于2012年人口普查为80-90%。
核心结论
- 出生队列分析清晰展示了务实补种活动后的人群水平HPV疫苗覆盖率,补种活动导致部分校外青少年存在覆盖缺口,但常规靶向12岁队列的覆盖率仍保持高位。
研究设计与样本
- 基于卢旺达扩大免疫规划(EPI)2011-2018年按日历年、女孩年龄、地区和接种轮次分层收集的 eligible girls 数和HPV疫苗交付数,按出生队列估算覆盖率。
主要发现
- 2011-2018年间1,156,863名女孩接种首剂HPV疫苗,相当于 eligible target 的98%。
- 中位接种年龄在2011-2013年(学校年级靶向补种)为15岁(IQR 13-16),2014年(过渡期)为13岁(IQR 12-14),2015-2018年(常规)为12岁。
- 相对于人口普查的人群覆盖率从1993-1995出生队列(中位接种年龄17岁)的10-40%升至1996-2000出生队列(14岁)的50-65%,再升至2001-2006出生队列(12岁)的80-90%。
- 各省份和首都基加利的覆盖率趋势相似。
- 第二和第三轮覆盖率提示大多数接种女孩完成了推荐剂量方案(该方案于2015年从3剂减为2剂)。
局限性
- 补种活动导致部分校外青少年存在覆盖缺口。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: In 2011, Rwanda became the first African nation to implement a national human papillomavirus (HPV) vaccination program, conceived to protect girls aged <15 years (i.e. born ≥1997). After an initial school-grade-targeted catch-up campaign, there was a transition to routine vaccination of 12 year-olds only. We aimed to produce population-level vaccine coverage estimates. METHODS: The Rwandan Expanded Program on Immunization (EPI) collected data on number of eligible girls and HPV vaccines delivered, stratified by calendar year (2011-2018), girl's age, district and vaccination round. HPV vaccine coverage was estimated by birth cohort (reconstituted using calendar year and age), as a proportion of (1) eligible target, and (2) the 2012 Rwandan census population. RESULTS: 1,156,863 girls received first dose of HPV vaccine between 2011 and 2018, corresponding to 98% of the eligible target. Median vaccination age was 15 years (interquartile range [IQR] 13-16) in 2011-2013 (school grade-targeted catch-up), 13 years (IQR 12-14) in 2014 (transition) and 12 years in 2015-2018 (routine). Population-level coverage versus the census increased from 10 to 40% for girls born in 1993-1995 (median vaccination age = 17 years) to 50-65% for 1996-2000 birth cohorts (14 years), and 80-90% for 2001-2006 birth cohorts (12 years). Coverage trends were similar across provinces and in the capital, Kigali. Second and third round coverage suggested most vaccinated girls completed their recommended dosing regimen (which reduced from 3 to 2 doses in 2015). CONCLUSIONS: Birth cohorts provide a clear picture of population-level HPV vaccine coverage after a pragmatic catch-up campaign, particularly in Rwanda where eligible school grades included wide age ranges. Whilst the catch-up campaign resulted in some coverage gaps in out-of-school teenagers, coverage remains high in cohorts routinely targeted as 12 year-olds.
引用
- Sayinzoga F, Umulisa MC, Sibomana H, et al. Human papillomavirus vaccine coverage in Rwanda: A population-level analysis by birth cohort. Vaccine. 2020. PMID: 32336599. doi:10.1016/j.vaccine.2020.04.021
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。